Hologic Agrees to Acquire Spanish Precision-Oncology Company Reveal Genomics

On 21 October, private-equity industry reporting covered an agreement by Hologic to acquire Barcelona-based Reveal Genomics, a company developing genomic diagnostic tests to support cancer treatment. The reported deal did not disclose a purchase price, so no transaction value can be verified from the available coverage. Healthcare providers, diagnostic laboratories and medical-technology businesses can explore opportunities in clinical data systems, diagnostic analytics and digital health infrastructure. HPC can support data integration, analytics and technology planning; contact HPC for a quotation, as no verified price for the acquisition was disclosed.